Department of Public Health, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
Department of Family Medicine, Faculty of Medicine, Ahi Evran University, Kirsehir, Turkey.
BMC Womens Health. 2022 Aug 4;22(1):331. doi: 10.1186/s12905-022-01916-6.
Cervical cancer is a preventable disease. This study aimed to share the results of the national cervical cancer screening program performed in primary health care institutions in Samsun between 2015 and 2019.
Women aged 30-65 years who were screened for cervical cancer in screening centers of Samsun between January 01, 2015, and December 31, 2019, were included in this descriptive study. The data were obtained from the automation program of the "National Human Papilloma Virus (HPV) Laboratory Application" used by the Provincial Directorate of Health Cancer Unit through filtering the completion time of the tests, and all results were evaluated without sampling. Thus, data were presented using descriptive statistics.
The mean age of 89,302 women included in the cervical cancer screening program was 45.9 ± 9.0 years. Of the samples obtained from the participants, 1.0% were determined as insufficient material, 94.1% as HPV-negative, and 4.9% as HPV-positive. The most common HPV genotypes were 16, 51, 31, and 52. Of the 4337 HPV-positive women, 74.7% of the pap smear results were negative (including infection, 36.5%), and the most common premalignant lesions were atypical squamous cells of undetermined significance in 7.1% and low-grade squamous intraepithelial lesions in 6.9%. HPV 16/18 was also observed in 31.7% of HPV-positive women. Seven hundred ninety-five women were referred to a specialist physician for further examination and treatment within the scope of the screening algorithm.
Detecting HPV-positivity by reaching more women within the national cervical cancer screening program's scope is vital in fighting against this disease. The effectiveness of cancer screening programs should be increased by ensuring community participation through awareness activities.
宫颈癌是一种可预防的疾病。本研究旨在分享 2015 年至 2019 年在萨姆松初级保健机构进行的全国宫颈癌筛查计划的结果。
本描述性研究纳入了 2015 年 1 月 1 日至 2019 年 12 月 31 日期间在萨姆松筛查中心接受宫颈癌筛查的 30-65 岁女性。通过过滤测试完成时间,从省卫生署癌症科使用的“国家人乳头瘤病毒(HPV)实验室应用”自动化程序中获取数据,并且所有结果都是在不抽样的情况下进行评估。因此,使用描述性统计数据呈现数据。
纳入宫颈癌筛查计划的 89302 名女性的平均年龄为 45.9±9.0 岁。从参与者中获得的样本中,1.0%被确定为材料不足,94.1%为 HPV 阴性,4.9%为 HPV 阳性。最常见的 HPV 基因型是 16、51、31 和 52。在 4337 名 HPV 阳性女性中,74.7%的巴氏涂片结果为阴性(包括感染,36.5%),最常见的癌前病变是意义未明的非典型鳞状细胞 7.1%和低度鳞状上皮内病变 6.9%。HPV 阳性女性中也观察到 HPV 16/18 占 31.7%。根据筛查算法,795 名女性被转介给专科医生进行进一步检查和治疗。
通过在全国宫颈癌筛查计划范围内让更多的女性接受 HPV 检测,对防治这种疾病至关重要。通过开展提高认识活动,确保社区参与,提高癌症筛查计划的效果。